CFTR mutations and IVS8-5T variant in newborns with hypertrypsinaemia and normal sweat test

被引:28
作者
Castellani, C
Bonizzato, A
Mastella, G
机构
[1] Cystic Fibrosis Centre, Ospedale Civile Maggiore, 37126 Verona, Piazzale Stefani
关键词
cystic fibrosis; hypertrypsinaemia; IVS8-5T variant;
D O I
10.1136/jmg.34.4.297
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Neonates positive for immunoreactive trypsinogen assay (IRT) and negative for sweat test have formerly been found to carry the major cystic fibrosis (CF) mutation, Delta F508, much more frequently than the general population. Among the 716 IRT positive newborns detected by a three tier (IRT, mutation analysis plus meconium lactase assay, sweat test) CF screening programme in north eastern Italy during the period January 1993 to March 1996, we found 45 carriers, a number significantly higher than the expected 17 (p<0.001). We speculated that some of these heterozygotes could actually be affected by a very mild form of CF, and carry on the other chromosome an undetected CFTR mutation or a DNA variant, such as the 5-thymidine allele in intron 8 of the CFTR gene (IVS8-5T). This hypothesis was tested in four samples: group A (the 45 carriers mentioned above), group B (51 non-carrier, IRT positive neonates), group C (50 IRT negative neonates), and group D (90 CF adult female carriers). Chromosomes with IVS8-5T were seven (7.78%) in group A, seven (6.86%) in group B, five (5%) in group C, and four in group D (2.22%). The 5T prevalence in group A was significantly higher (p<0.05) compared to group D; similarly, a higher (p<0.05) 5T frequency in group A compared to group C was detected by considering the chromosomes free from CFTR mutations. This study is consistent with previous papers in finding among neonates with high trypsin levels a CF carrier frequency significantly higher than that expected. It is also suggested that in at least some babies raised trypsin levels at birth could be a phenotypic expression of compound heterozygosity for a major CF mutation plus IVS8-5T.
引用
收藏
页码:297 / 301
页数:5
相关论文
共 26 条
[1]  
BONIZZATO A, 1995, HUM GENET, V95, P397
[2]   AN EVALUATION OF AN ENZYME-IMMUNOASSAY METHOD FOR IMMUNOREACTIVE TRYPSIN IN DRIED BLOOD SPOTS [J].
CABRINI, G ;
PEDERZINI, F ;
PEROBELLI, L ;
MASTELLA, G .
CLINICAL BIOCHEMISTRY, 1990, 23 (03) :213-219
[3]  
CHEHAB FF, 1992, HUM GENET, V89, P163
[4]   MUTATIONS IN THE CYSTIC-FIBROSIS GENE IN PATIENTS WITH CONGENITAL ABSENCE OF THE VAS-DEFERENS [J].
CHILLON, M ;
CASALS, T ;
MERCIER, B ;
BASSAS, L ;
LISSENS, W ;
SILBER, S ;
ROMEY, MC ;
RUIZROMERO, J ;
VERLINGUE, C ;
CLAUSTRES, M ;
NUNES, V ;
FEREC, C ;
ESTIVILL, X .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (22) :1475-1480
[5]   GENETIC-BASIS OF VARIABLE EXON-9 SKIPPING IN CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MESSENGER-RNA [J].
CHU, CS ;
TRAPNELL, BC ;
CURRISTIN, S ;
CUTTING, GR ;
CRYSTAL, RG .
NATURE GENETICS, 1993, 3 (02) :151-156
[6]  
CROSSLEY JR, 1979, LANCET, V1, P472
[7]   CFTR HAPLOTYPE BACKGROUNDS ON NORMAL AND MUTANT CFTR GENES [J].
CUPPENS, H ;
TENG, H ;
RAEYMAEKERS, P ;
DEBOECK, C ;
CASSIMAN, JJ .
HUMAN MOLECULAR GENETICS, 1994, 3 (04) :607-614
[8]  
DANKERTROELSE JE, 1994, CYSTIC FIBROSIS CURR, P303
[9]  
DORK T, 1994, HUM GENET, V93, P67
[10]   Complexity in a monogenic disease [J].
Estivill, X .
NATURE GENETICS, 1996, 12 (04) :348-350